News
CASIF
0.117
-33.14%
-0.058
Weekly Report: what happened at CASIF last week (0615-0619)?
Weekly Report · 20h ago
Weekly Report: what happened at CASIF last week (0608-0612)?
Weekly Report · 06/15 10:35
Weekly Report: what happened at CASIF last week (0601-0605)?
Weekly Report · 06/08 10:30
CASI Pharmaceuticals Director Resigns but Stays On as Consultant
TipRanks · 06/02 11:01
CASI Pharmaceuticals director Barbara Krebs-Pohl resigns effective May 31, 2026
PUBT · 06/02 10:31
Weekly Report: what happened at CASIF last week (0525-0529)?
Weekly Report · 06/01 10:36
Weekly Report: what happened at CASIF last week (0518-0522)?
Weekly Report · 05/25 10:40
Weekly Report: what happened at CASIF last week (0511-0515)?
Weekly Report · 05/18 10:39
CASI Pharmaceuticals FY25 net loss widens to US$48.06 million; revenue falls 27.3% to US$20.71 million
PUBT · 05/15 10:23
Weekly Report: what happened at CASIF last week (0504-0508)?
Weekly Report · 05/11 10:36
Weekly Report: what happened at CASIF last week (0427-0501)?
Weekly Report · 05/04 10:33
Weekly Report: what happened at CASIF last week (0420-0424)?
Weekly Report · 04/27 10:36
CASI Pharmaceuticals Delays Annual 20-F Filing
TipRanks · 04/21 12:17
CASI Pharmaceuticals Reshapes Medical Leadership Amid U.S. Streamlining Drive
TipRanks · 04/20 21:03
CASI Pharmaceuticals Closes Final US$5 Million Tranche of US$20 Million Convertible Notes
TipRanks · 04/20 13:24
Weekly Report: what happened at CASIF last week (0413-0417)?
Weekly Report · 04/20 10:31
CASI Pharmaceuticals Begins Trading on OTCQB Under Ticker CASIF
TipRanks · 04/15 13:54
Weekly Report: what happened at CASIF last week (0406-0410)?
Weekly Report · 04/13 10:36
Weekly Report: what happened at CASIF last week (0330-0403)?
Weekly Report · 04/06 10:36
Weekly Report: what happened at CASIF last week (0323-0327)?
Weekly Report · 03/30 10:37
More
Webull provides a variety of real-time CASIF stock news. You can receive the latest news about Casi Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About CASIF
CASI Pharmaceuticals Inc is a holding company principally engaged in developing and commercializing innovative therapeutics and pharmaceutical products. The Company’s main business is engaged in acquiring, developing and commercializing products that augment its hematology oncology, autoimmune and organ transplant rejection therapeutic area focus as well as other unmet medical need. The Company’s main products include EVOMELA (Melphalan for Injection), FOLOTYN (Pralatrexate), CNCT19, BI-1206, CB-5339, CID-103, Thiotepa and others. The Company mainly conducts its business in the domestic market.